New Advances in Organ Engineering and Transplantation
A special issue of Medicina (ISSN 1648-9144).
Deadline for manuscript submissions: closed (1 February 2022) | Viewed by 301
Special Issue Editors
2. Department of Surgery, Hepatology and Transplantation Laboratory, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Interests: regenerative medicine; regenerative surgery; organ bioengineering; artificial organs; liver transplantation; pancreas transplantation; kidney transplantation
2. Tissue Engineering and Organ Regeneration Laboratory, Department of Surgery, Faculty of Medicine, University of Geneva, Geneva, Switzerland
3. Institute of Medical Research, Ilia State University, Tbilisi, Georgia
Interests: tissue engineering; organ regeneration; pancreas bioengineering; islet transplantation; regenerative medicine; cell-on-scaffold technology
Special Issue Information
Dear Colleagues,
The lack of transplantable organs is now the real restrictive factor affecting all end-stage disease therapy. In this scenario, the emergence of regenerative medicine is changing research toward the creation of ad-hoc organs made in the laboratory trying to bypass this limit.
Regenerative medicine encompasses various combinations of specially grown cells, tissues, and laboratory-made compounds to replace or amplify the body’s natural healing process holding the potential to impact the whole spectrum of the healthcare system.
The latest breakthrough advances in regenerative medicine have earned unparalleled media attention, fostering curiosity and excitement in transplant community.
Nevertheless, the main hurdles to progress include a better understanding of the dynamics governing (in vitro and in vivo) cell biology and organ bioengineering.
The goal of this Special Issue is to promote this new scientific discipline by compiling all relevant papers, divided into reviews and original research articles. Furthermore, we aim to bring together an interdisciplinary group of individuals to exchange their expertise and further stimulate their research and development activities.
This Special Issue welcomes manuscripts on regenerative medicine and organ bioengineering.
Areas of interest include but are not limited to:
- Regenerative medicine;
- Tissue/organ bioengineering;
- 3D printing;
- Organ-on-chip technology.
“How-to” or “methods” articles about practical application of regeneration strategies are also welcomed.
Dr. Andrea Peloso
Dr. Ekaterine Berishvili
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- regenerative medicine
- organ bioengineering
- tissue engineering
- organ regeneration
- pancreas bioengineering
- regenerative medicine
- cell-on-scaffold technology
